Literature DB >> 34985711

Non-psychoactive cannabinoids identification by linear retention index approach applied to a hand-portable capillary liquid chromatography platform.

Roberta La Tella1, Francesca Rigano2, Paolo Guarnaccia3, Paola Dugo1,4, Luigi Mondello1,4,5,6.   

Abstract

The aim of the present research was the application of the linear retention index (LRI) system for the identification of non-psychoactive cannabinoids using a portable LC instrument. The miniaturization, viz. the use of very low quantities of mobile phase, enabled the development of a compact mobile system to be used for in situ analysis, also according to a green and cost-saving approach. In particular, new capillary LC (cap-LC) methods coupled with UV detection were developed for the analysis of extracts of Cannabis sativa L. Two setups were explored to achieve the efficient separation of twenty-four cannabinoids: a single column setup which exploited a sub-2 µm packing to increase the chromatographic resolution, and a dual-column setup based on the serial connection of two different stationary phases, each coupled to an UV detector. The latter allowed the determination of two LRI values for each analyte, thus increasing the identification power. Moreover, since two different wavelengths were used on the LED-based UV detectors, the ratio of the absorbances measured on each chromatographic trace represented a third identification criterion, thus fulfilling the recommendations of the Scientific Working Group for The Analysis of Seized Drugs (SWDRUG) about the categories of analytical techniques to be used and the minimum number of parameters required for the unambiguous identification of drugs. The obtained results could be used for the development of a novel analytical method for fast and automatic in situ forensic investigations and hemp breeding programs, also minimizing the consumption of both sample and solvent.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Breeding programs; Cannabis sativa; Capillary LC; Forensic analysis; Miniaturization; Portable instrumentation

Mesh:

Substances:

Year:  2022        PMID: 34985711     DOI: 10.1007/s00216-021-03871-x

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  30 in total

1.  Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.

Authors:  Antonella Smeriglio; Salvatore V Giofrè; Enza M Galati; Maria T Monforte; Nicola Cicero; Valeria D'Angelo; Gianpaolo Grassi; Clara Circosta
Journal:  Fitoterapia       Date:  2018-02-07       Impact factor: 2.882

2.  A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High-Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts.

Authors:  Cinzia Citti; Umberto Maria Battisti; Daniela Braghiroli; Giuseppe Ciccarella; Martin Schmid; Maria Angela Vandelli; Giuseppe Cannazza
Journal:  Phytochem Anal       Date:  2017-09-15       Impact factor: 3.373

Review 3.  Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence.

Authors:  Cinzia Citti; Fabiana Russo; Salvatore Sgrò; Alfonso Gallo; Antonio Zanotto; Flavio Forni; Maria Angela Vandelli; Aldo Laganà; Carmela Maria Montone; Giuseppe Gigli; Giuseppe Cannazza
Journal:  Anal Bioanal Chem       Date:  2020-04-14       Impact factor: 4.142

4.  Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp).

Authors:  Virginia Brighenti; Federica Pellati; Marleen Steinbach; Davide Maran; Stefania Benvenuti
Journal:  J Pharm Biomed Anal       Date:  2017-06-04       Impact factor: 3.935

5.  Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes.

Authors:  Nandakumara D Sarma; Andrew Waye; Mahmoud A ElSohly; Paula N Brown; Sytze Elzinga; Holly E Johnson; Robin J Marles; Jeremy E Melanson; Ethan Russo; Lawrence Deyton; Christopher Hudalla; Gordon A Vrdoljak; Joshua H Wurzer; Ikhlas A Khan; Nam-Cheol Kim; Gabriel I Giancaspro
Journal:  J Nat Prod       Date:  2020-04-13       Impact factor: 4.050

6.  Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.

Authors:  Xavier Nadal; Carmen Del Río; Salvatore Casano; Belén Palomares; Carlos Ferreiro-Vera; Carmen Navarrete; Carolina Sánchez-Carnerero; Irene Cantarero; Maria Luz Bellido; Stefan Meyer; Gaetano Morello; Giovanni Appendino; Eduardo Muñoz
Journal:  Br J Pharmacol       Date:  2017-11-02       Impact factor: 8.739

7.  Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.

Authors:  Shuso Takeda; Shunsuke Okajima; Hiroko Miyoshi; Kazutaka Yoshida; Yoshiko Okamoto; Tomoko Okada; Toshiaki Amamoto; Kazuhito Watanabe; Curtis J Omiecinski; Hironori Aramaki
Journal:  Toxicol Lett       Date:  2012-09-08       Impact factor: 4.372

Review 8.  A review of methods for the chemical characterization of cannabis natural products.

Authors:  Allegra Leghissa; Zacariah L Hildenbrand; Kevin A Schug
Journal:  J Sep Sci       Date:  2017-12-14       Impact factor: 3.645

9.  Antitumor Cannabinoid Chemotypes: Structural Insights.

Authors:  Paula Morales; Nadine Jagerovic
Journal:  Front Pharmacol       Date:  2019-05-31       Impact factor: 5.810

Review 10.  Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.

Authors:  José A Crippa; Francisco S Guimarães; Alline C Campos; Antonio W Zuardi
Journal:  Front Immunol       Date:  2018-09-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.